<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bekhterev</journal-id><journal-title-group><journal-title xml:lang="ru">Обозрение психиатрии и медицинской психологии имени В.М.Бехтерева</journal-title><trans-title-group xml:lang="en"><trans-title>V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7053</issn><issn pub-type="epub">2713-055X</issn><publisher><publisher-name>V. M. BEKHTEREV  NATIONAL  RESEARCH  MEDICAL  CENTER  FOR  PSYCHIATRY  AND  NEUROLOGY                           OF    THE  RUSSIAN  FEDERATION   MINISTRY  OF  HEALTH</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31363/2313-7053-2020-4-26-32</article-id><article-id custom-type="elpub" pub-id-type="custom">bekhterev-482</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Использование метода количественной ЭЭГ в прогнозировании ответа на терапию аффективных расстройств</article-title><trans-title-group xml:lang="en"><trans-title>Using the quantitative EEG method in predicting the response to treatment of affective disorders</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7709-3917</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галкин</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Galkin</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">s01091994@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7600-7557</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильева</surname><given-names>С. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasilieva</surname><given-names>S. N.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">vasilievasn@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9813-3789</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Симуткин</surname><given-names>Г. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Simutkin</surname><given-names>G. G.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">ggsimutkin@gmail.co</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ткачева</surname><given-names>Г. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Tkacheva</surname><given-names>G. D.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">mental@tnimc.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ошкина</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Oshkina</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">mental@tnimc.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7078-323X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванова</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanova</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">ivanovaniipz@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1052-855X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бохан</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bokhan</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">mental@tnimc.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт психического здоровья, Томский национальный исследовательский медицинский центр Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Mental Health Research Institute; Tomsk National Research Medical Center (NRMC) of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Научно-исследовательский институт психического здоровья; Томский национальный исследовательский медицинский центр Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Mental Health Research Institute; Tomsk National Research Medical Center (NRMC) of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Научно-исследовательский институт психического здоровья; Томский национальный исследовательский медицинский центр Российской академии наук; ФГБОУ ВО «Сибирский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Mental Health Research Institute; Tomsk National Research Medical Center (NRMC) of the Russian Academy of Sciences;&#13;
Siberian State Medical University (SSMU)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>16</day><month>12</month><year>2020</year></pub-date><volume>0</volume><issue>4</issue><fpage>26</fpage><lpage>32</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Галкин С.А., Васильева С.Н., Симуткин Г.Г., Ткачева Г.Д., Ошкина Т.А., Иванова С.А., Бохан Н.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Галкин С.А., Васильева С.Н., Симуткин Г.Г., Ткачева Г.Д., Ошкина Т.А., Иванова С.А., Бохан Н.А.</copyright-holder><copyright-holder xml:lang="en">Galkin S.A., Vasilieva S.N., Simutkin G.G., Tkacheva G.D., Oshkina T.A., Ivanova S.A., Bokhan N.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.bekhterevreview.com/jour/article/view/482">https://www.bekhterevreview.com/jour/article/view/482</self-uri><abstract><p>Цель — изучить особенности мозговой активности у пациентов с аффективными расстройствами в зависимости от ответа на проводимую терапию.</p><sec><title>Материал и методы</title><p>Материал и методы. В исследование было включено 84 пациента с аффективным расстройством. Все пациенты получали синдромально обусловленную психофармакотерапию, включавшую антидепрессанты и нормотимические препараты. Выраженность аффективного расстройства оценивали с помощью шкалы депрессии Гамильтона. Критерием эффективности терапии (чувствительности) служило улучшение клинических симптомов на 50% и более, оцениваемое с помощью шкалы Гамильтона. Исследование выполнялось в два этапа (точки): в первой точке пациенты обследовались при поступлении в отделение до начала приема лекарственных препаратов (проводилась запись электроэнцефалограммы и заполнение шкалы Гамильтона), вторая точка выполнялась после 4-х недельного курса лечения пациентов в стационаре (заполнение шкалы Гамильтона). Регистрация и анализ биоэлектрической активности головного мозга осуществлялась при помощи 16 канального энцефалографа. Сигналы обрабатывались с помощью быстрого преобразования Фурье, анализировались значения абсолютной спектральной мощности (мкВ²) для θ — (4 — 7 Гц), α — (8 — 13 Гц) и β — (14 — 30 Гц) ритмов.</p></sec><sec><title>Результаты</title><p>Результаты. Анализ спектральной мощности электроэнцефалографических ритмов в покое с закрытыми глазами показал статистически значимо более высокие значения альфа-ритма во фронтальной (р=0,044) и теменной (0,049) коре, бета-ритма во фронтальной коре (р=0,048) и тета-ритма во фронтальной (р=0,0004), центральной (р=0,009), теменной (р=0,003) и затылочной (р=0,001) коре у пациентов, нечувствительных к терапии по сравнению с респондентами.</p></sec><sec><title>Заключение</title><p>Заключение. В нашем исследовании были выявлены значимые различия показателей количественной электроэнцефалограммы между пациентами с аффективными расстройствами в зависимости от чувствительности на проводимую терапию. Полученные результаты показывают, что существуют аспекты количественной электроэнцефалограммы, которые связаны с реакцией на фармакологическое лечение аффективных расстройств.</p></sec></abstract><trans-abstract xml:lang="en"><p>The aim is to study the features of brain activity in patients with affective disorders, depending on the response to therapy. Material and methods. The study included 84 patients with affective disorder. All patients received syndrome-induced psychopharmacotherapy, which included antidepressants and normotimic drugs. The severity of affective disorder was assessed using the Hamilton depression scale. The criterion for the effectiveness of therapy (sensitivity) was an improvement in clinical symptoms by 50% or more, estimated using the Hamilton scale. The study was performed in two stages (points): at the first point, patients were examined upon admission to the Department before taking medications (electroencephalogram recording and filling in the Hamilton scale were performed), the second point was performed after a 4-week course of treatment of patients in the hospital (filling in the Hamilton scale). Registration and analysis of bioelectric activity of the brain was carried out using a 16-channel encephalograph. The signals were processed using fastFourier transform, and the values of absolute spectral power (mV2) for θ — (4 — 7 Hz), α — (8 — 13 Hz) and β — (14 — 30 Hz) rhythms were analyzed.</p><sec><title>Results</title><p>Results. Analysis of the spectral power of electroencephalographic rhythms at rest with closed eyes showed statistically significantly higher values of alpha-rhythm in the frontal(p=0.044) and parietal (0.049) cortex, beta-rhythm in the frontal cortex (p=0.048) and theta-rhythm in the frontal (p=0.0004), Central (p=0.009), parietal (p=0.003) and occipital (p=0.001) cortex in patients who were not sensitive to therapy for compared to respondents.</p></sec><sec><title>Conclusion</title><p>Conclusion. Our study revealed significant differences in quantitative electroencephalogram parameters between patients with affective disorders, depending on the sensitivity to the therapy. The results show that there are aspects of quantitative electroencephalogram thatare related to the response to pharmacological treatment of affective disorders.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>аффективные расстройства</kwd><kwd>прогноз терапии</kwd><kwd>электроэнцефалография</kwd><kwd>антидепрессанты</kwd><kwd>диагностика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>affective disorders</kwd><kwd>prognosis of therapy</kwd><kwd>electroencephalography</kwd><kwd>antidepressants</kwd><kwd>diagnostics</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Галкин С.А., Пешковская А.Г., Симуткин Г.Г., Васильева С.Н., Рощина О.В., Иванова С.А., Бохан Н.А. Нарушения функции пространственной рабочей памяти при депрессии легкой степени тяжести и их нейрофизиологические корреляты. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;10:56-61.</mixed-citation><mixed-citation xml:lang="en">Galkin SA, Peshkovskaya AG, Simutkin GG, Vasileva SN, Roshchina OV, Ivanova SA, Bokhan NA. Violations of the function of spatial working memory in mild depression and their neurophysiological correlates. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2019;10:56-61. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Галкин С.А., Симуткин Г.Г., Васильева С.Н., Иванова С.А. Сравнительный анализ ЭЭГ при аффективных расстройствах различного генеза. Психическое здоровье. 2019;9:36-43.</mixed-citation><mixed-citation xml:lang="en">Galkin SA, Simutkin GG, Vasileva SN, Ivanova SA. The Comparative analysis of the EEG in affective disorders of different Genesis. Psihicheskoe zdorov’e. 2019;9:36-43. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Изнак А.Ф., Изнак Е.В., Сорокин С.А. Изменения ЭЭГ и времени реакции в процессе терапии апатической депрессии. Журнал неврологии и психиатрии им. С. С. Корсакова. 2011;7:49-53.</mixed-citation><mixed-citation xml:lang="en">Iznak AF, Iznak EV, Sorokin SA. Changes in EEG and reaction time in the treatment of apathetic depression. Zhurnal nevrologii i psihiatrii im. S. S. Korsakova. 2011;7:49-53. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Караваева Т.А., Васильева А.В., Полторак С.В., Чехлатый Е.И., Лукошкина Е.П. Критерии и алгоритм диагностики генерализованного тревожного расстройства. Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева. 2015;3:124-130.</mixed-citation><mixed-citation xml:lang="en">Karavaeva TA, Vasilyeva AV, Poltorak SV, Chekhlatyi EI, Lukoshkina EP. Criteria and algorithm for the diagnosis of generalized anxiety disorder. Obozrenie psihiatrii i medicinskoj psihologii imeni V.M. Behtereva. 2015;3:124-130. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Краснов В.Н. Депрессия как социальная и клиническая проблема современной медицины. Российский психиатрический журнал. 2011;6:8-10.</mixed-citation><mixed-citation xml:lang="en">Krasnov VN. Depression as a social and clinical problem of modern medicine. Rossijskij psihiatricheskij zhurnal. 2011;6:8-10. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Лапин И.А., Алфимова М.В. ЭЭГ-маркеры депрессивных состояний. Социальная и клиническая психиатрия. 2014;4:81-89.</mixed-citation><mixed-citation xml:lang="en">Lapin IA, Alfimov MV. EEG-markers of depression. Social’naja i klinicheskaja psihiatrija. 2014;4:81-89. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Мазо Г.Э., Горбачев С.Е., Петрова Н.Н. Терапевтически резистентные депрессии: современные подходы к диагностике и лечению. Вестник Санкт-Петербургского университета. 2008;2:87-99.</mixed-citation><mixed-citation xml:lang="en">Mazo GE, Gorbachev SE, Petrova NN. Therapeutically resistant depressions: modern approaches to diagnosis and treatment. Vestnik Sankt-Peterburgskogo universiteta. 2008;2:87-99. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Arns M, Etkin M, Hegerl U, Williams L, DeBattista C. Frontal and rostral anterior cingulated (rACC) theta EEG in depression: implications for treatment outcome? Eur. Neuropsychopharmacology. 2015;25:7. doi:10.1016/j.euroneuro.2015.03.007</mixed-citation><mixed-citation xml:lang="en">Arns M, Etkin M, Hegerl U, Williams L, DeBattista C. Frontal and rostral anterior cingulated (rACC) theta EEG in depression: implications for treatment outcome? Eur. Neuropsychopharmacology. 2015;25:7. doi:10.1016/j.euroneuro.2015.03.007</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cook I, Leuchter A, Morgan M, Witte E, Stubbeman WF, Abrams M. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology. 2002;27:120-131. doi:10.1016/S0893-133X(02)00294-4</mixed-citation><mixed-citation xml:lang="en">Cook I, Leuchter A, Morgan M, Witte E, Stubbeman WF, Abrams M. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology. 2002;27:120-131. doi:10.1016/S0893-133X(02)00294-4</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Jung WY, Jang SH, Kim SG. Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive Disorder. Psychiatry Investig. 2016;4:440-446. doi:10.4306/pi.2016.13.4.440</mixed-citation><mixed-citation xml:lang="en">Jung WY, Jang SH, Kim SG. Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive Disorder. Psychiatry Investig. 2016;4:440-446. doi:10.4306/pi.2016.13.4.440</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Knott V, Mahoney C, Kennedy S, Evans K. Pretreatment EEG and it’s relationship to depression severity and paroxetine treatment outcome. Pharmacopsychiatry. 2000;33:201-205. doi:10.1055/s-2000-8356</mixed-citation><mixed-citation xml:lang="en">Knott V, Mahoney C, Kennedy S, Evans K. Pretreatment EEG and it’s relationship to depression severity and paroxetine treatment outcome. Pharmacopsychiatry. 2000;33:201-205. doi:10.1055/s-2000-8356</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Olbrich S, van Dinteren R, Arns M. Personalized medicine: review and perspectives of promising baseline EEG biomarkers in major depressive disorder and attention deficit hyperactivity disorder. Neuropsychobiology. 2015;72:229-240. doi:10.1159/000437435</mixed-citation><mixed-citation xml:lang="en">Olbrich S, van Dinteren R, Arns M. Personalized medicine: review and perspectives of promising baseline EEG biomarkers in major depressive disorder and attention deficit hyperactivity disorder. Neuropsychobiology. 2015;72:229-240. doi:10.1159/000437435</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Pizzagalli D. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology. 2011;36:183-206. doi:10.1038/npp.2010.166</mixed-citation><mixed-citation xml:lang="en">Pizzagalli D. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology. 2011;36:183-206. doi:10.1038/npp.2010.166</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Pizzagalli D, Webb C, Dillon D, Tenke C, Kayser J, Goer F. Pretreatment rostral anterior cingulated cortex theta activity in relation to symptom improvement in depression: a randomized clinical trial. JAMA Psychiatry. 2018;75:252. doi:10.1001/jamapsychiatry.2018.0252</mixed-citation><mixed-citation xml:lang="en">Pizzagalli D, Webb C, Dillon D, Tenke C, Kayser J, Goer F. Pretreatment rostral anterior cingulated cortex theta activity in relation to symptom improvement in depression: a randomized clinical trial. JAMA Psychiatry. 2018;75:252. doi:10.1001/jamapsychiatry.2018.0252</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Roohi-Azizi M, Azimi L, Heysieattalab S, Aamidfar M. Changes of the brain’s bioelectrical activity in cognition, consciousness, and some mental disorders. Med. J. Islam. Repub. Iran. 2017;31:53. doi:10.14196/mjiri.31.53</mixed-citation><mixed-citation xml:lang="en">Roohi-Azizi M, Azimi L, Heysieattalab S, Aamidfar M. Changes of the brain’s bioelectrical activity in cognition, consciousness, and some mental disorders. Med. J. Islam. Repub. Iran. 2017;31:53. doi:10.14196/mjiri.31.53</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Schiller MJ. Quantitative Electroencephalography in Guiding Treatment of Major Depression. Front. Psychiatry. 2019;9:779 doi:10.3389/fpsyt.2018.00779</mixed-citation><mixed-citation xml:lang="en">Schiller MJ. Quantitative Electroencephalography in Guiding Treatment of Major Depression. Front. Psychiatry. 2019;9:779 doi:10.3389/fpsyt.2018.00779</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Trautmann S, Rehm J, Wittchen HU. The economic costs of mental disorders: Do our societies react appropriately to the burden of mental disorders? EMBO Rep. 2016;9:1245–1249. doi:10.15252/embr.201642951</mixed-citation><mixed-citation xml:lang="en">Trautmann S, Rehm J, Wittchen HU. The economic costs of mental disorders: Do our societies react appropriately to the burden of mental disorders? EMBO Rep. 2016;9:1245–1249. doi:10.15252/embr.201642951</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wade EC, Iosifescu DV. Using electroencephalography for treatment guidance in major depressive disorder. Biol. Psychiatry Cogn. Neurosci. Neuroimaging. 2016;1:411-422.</mixed-citation><mixed-citation xml:lang="en">Wade EC, Iosifescu DV. Using electroencephalography for treatment guidance in major depressive disorder. Biol. Psychiatry Cogn. Neurosci. Neuroimaging. 2016;1:411-422.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Wainberg ML, Scorza P, Shultz JM. Challenges and Opportunities in Global Mental Health: a Research-to-Practice Perspective. Curr. Psychiatry. Rep. 2017;5:28. doi:10.1007/s11920-017-0780-z</mixed-citation><mixed-citation xml:lang="en">Wainberg ML, Scorza P, Shultz JM. Challenges and Opportunities in Global Mental Health: a Research-to-Practice Perspective. Curr. Psychiatry. Rep. 2017;5:28. doi:10.1007/s11920-017-0780-z</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
